Pharmafile Logo

Management Forum Ltd

Since 1983, we have built our reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world’s most demanding industries. Based in Woking, Surrey, UK, we use our accumulated skills, expertise and speaker and media networks to deliver enlightening events, training programs and top-level School and Master class sessions for Pharmaceutical, Animal Health, Medical Devices, Legal and Intellectual Property professionals around the world.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

98-100 Maybury Road, Woking, Surrey, GU21 5JL, United Kingdom
+44 (0)1483 730071

 Latest Content from PMHub 

The Eleven guide to NFTs

Press Releases | March 24, 2022 | 11 London

Non-Fungible Tokens (NFTs) have been making waves in the news lately, specifically around the millions of dollars being exchanged for unique digital art assets. Investors have been queuing up to...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

The power of influence in transforming women’s health

Over the past four years HRT prescriptions have doubled in the UK, the cause was turbo charged by the action of celebrities and influencers.

KVA launch the KVA Mediverse, leading the way in VR healthcare comms

Press Releases | March 23, 2022 | KVA

KVA announce their new unique VR offering

Nucleus Global launches Nucleus X Consulting, a specialist consultancy with deep expertise in patient engagement, rare disease, and early-phase medical commercialization

Press Releases | March 22, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, announces the launch of a new consultancy to add to its family of agencies. Nucleus X Consulting consists of...

Top 10 Most Common Participant Comments – Online Advisory Boards

What advisors and participants have to say about the Impetus InSite Platform!

Healthcare services entrepreneur David Rowley joins KVA

Press Releases | March 21, 2022 | KVA

KVA appoints David Rowley to act as advisor to the board

Engaging doctors around the globe

Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies...

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

Press Releases | March 21, 2022 | OPEN Health

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access